Evidence map›Paper›PMID 35813203›Full record

ReviewFrontiers in cell and developmental biology2022

WNK1 in Malignant Behaviors: A Potential Target for Cancer?

Ji-Ung Jung, Ankita B Jaykumar, Melanie H Cobb

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Targeting WNK1 Releases Differentiation Block in Acute Myeloid Leukemia.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. WNK1 controls endosomal trafficking through TRIM27-dependent regulation of actin assembly.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ji-Ung JungDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX, United States.
Ankita B JaykumarDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX, United States.
Melanie H CobbDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX, United States.
The University of Texas Southwestern Medical Center · USSouthwestern Medical Center · US

Funding

WNK and TGF-beta in Endothelial MigrationR01HL147661 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 2019 to 2022
$1.6M
NHLBI NIH HHS R01 HL147661
6 · The paper itself

Abstract

Metastasis is the major cause of mortality in cancer patients. Analyses of mouse models and patient data have implicated the protein kinase WNK1 as one of a handful of genes uniquely linked to a subset of invasive cancers. WNK1 signaling pathways are widely implicated in the regulation of ion co-transporters and in controlling cell responses to osmotic stress. In this review we will discuss its actions in tumor malignancy in human cancers and present evidence for its function in invasion, migration, angiogenesis and mesenchymal transition.

Indexed as

EMTOSR1SPAKTGF-βWNK1

Identifiers

PMID35813203
PMCPMC9257110
OpenAlexW4283375798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.